"ADE of SARS-CoV-2 infection is a major concern for the development of antibody-based vaccines and therapeutics. ADE could increase the severity of several viral infections, including Respiratory Syncytial virus (RSV), Dengue virus, Zika virus, SARS-CoV and Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"